1-4 of 4
Joost van Veen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy

CME Clinical Trials & Observations
Andrew J. Doyle, Matthew J. Stubbs, Tina Dutt, Will Lester, Will Thomas, Joost van Veen, Joannes Hermans, Tanya Cranfield, Quentin A. Hill, Amanda Clark, Catherine Bagot, Steven Austin, John-Paul Westwood, Mari Thomas, Marie Scully
Journal: Blood
Blood (2023) 141 (3): 285–294.
https://doi.org/10.1182/blood.2022017023
Published: 2023
Journal Articles

Characterizing the United Kingdom Congenital Thrombotic Thrombocytopenic Purpura Population

Ferras Alwan, MBBS, Chiara Vendramin, Ri Liesner, Tina Dutt, Amanda Clark, Jayashree Motwani, Will Lester, Vickie McDonald, Rachel Rayment, Nichola Cooper, MA, MD MRCP, FRCPath, Richard Gooding, Hamish Lyall, Tina Biss, MD, Joost van Veen, Henry G Watson, John-Paul Westwood, Mari Thomas, Marie Scully
Journal: Blood
Blood (2017) 130 (Supplement 1): 3616.
https://doi.org/10.1182/blood.V130.Suppl_1.3616.3616
Published: 2017
Journal Articles

Reversal of Anticoagulation as Assessed by Thrombin Generation Measurement.

Alex Gatt, MD, Joost van Veen, MD, Peter Cooper, Steve Kitchen, PhD, Michael Makris, MD
Journal: Blood
Blood (2006) 108 (11): 876.
https://doi.org/10.1182/blood.V108.11.876.876
Published: 2006
Journal Articles

A Novel Protac®-Modified Thrombin Generation Assay To Identify Individuals at Higher Thrombotic Risk.

Alex Gatt, MD, Joost van Veen, MD, Peter Cooper, Steve Kitchen, PhD, Michael Makris, MD
Journal: Blood
Blood (2006) 108 (11): 1472.
https://doi.org/10.1182/blood.V108.11.1472.1472
Published: 2006